Department of Ophthalmology, Kaiser Permanente Medical Group, San Francisco Medical Center, San Francisco, CA.
J Glaucoma. 2024 Sep 1;33(9):645-651. doi: 10.1097/IJG.0000000000002417. Epub 2024 May 6.
Long-term success was achievable after GATT. GATT performed at early stage of glaucoma had better surgery outcomes. Trabeculoplasty may compromise surgery success.
To evaluate the long-term effectiveness of prolene suture gonioscopy-assisted transluminal trabeculotomy (GATT) and identify factors that may affect surgical outcomes.
This is a retrospective cohort study of adult patients with prolene suture GATT performed by a single surgeon at 1 medical center.
Of the 145 eyes from 124 patients studied, intraocular pressure was reduced from 22.1±7.8 to 15.1±3.2 and 15.1±3.5 mm Hg, and the number of glaucoma medications was reduced from 3.2±1.1 to 1.3±1.4 and 1.4±1.5 at postoperative years 3 and 4, respectively. Ninety-three and 71 eyes completed a 3- and 4-year follow-up, with 44% of the eyes at year 4 remaining medication free. Compared with eyes with combined GATT/cataract extraction (CE), eyes with GATT alone had significantly more preoperative medications and a higher reoperation rate (31% vs. 16.5%). Eyes with prior trabeculoplasty had a higher reoperation rate (28.8%) than those without (16.1%). Kaplan-Meier survival analysis revealed that GATT/CE eyes without trabeculoplasty had a longer median time to failure (48 mo) than GATT/CE eyes with trabeculoplasty (18 mo), and GATT eyes with or without trabeculoplasty (9 and 12 mo, respectively).
Prolene suture GATT successfully reduced IOP. Eyes with more preoperative medications responded less well to GATT. Prior laser trabeculoplasty was associated with poorer outcomes. Further study is needed to verify these findings.
GATT 后可实现长期成功。GATT 在青光眼早期阶段的手术效果更好。小梁成形术可能会影响手术成功率。
评估普里灵缝线青光眼房角切开术(GATT)的长期有效性,并确定可能影响手术结果的因素。
这是一项回顾性队列研究,纳入了 1 家医疗中心的 1 名外科医生为 124 例患者施行普里灵缝线 GATT 的 145 只眼。
在术后 3 年和 4 年,145 只眼中的 124 例患者的眼内压分别从 22.1±7.8mmHg 降至 15.1±3.2mmHg 和 15.1±3.5mmHg,青光眼药物数量分别从 3.2±1.1 降至 1.3±1.4 只和 1.4±1.5 只。93 只眼和 71 只眼完成了 3 年和 4 年的随访,其中 44%的眼在第 4 年时无需药物治疗。与 GATT/白内障超声乳化吸除术(CE)联合治疗的眼相比,单独施行 GATT 的眼术前用药更多,再手术率更高(31%比 16.5%)。曾行小梁成形术的眼再手术率(28.8%)高于未行小梁成形术的眼(16.1%)。Kaplan-Meier 生存分析显示,无小梁成形术的 GATT/CE 眼的中位失败时间(48 个月)长于有小梁成形术的 GATT/CE 眼(18 个月),且 GATT 眼无论有无小梁成形术,其失败时间分别为 9 个月和 12 个月。
普里灵缝线 GATT 成功降低了眼压。术前用药更多的眼对 GATT 的反应较差。既往激光小梁成形术与较差的结果相关。需要进一步研究来验证这些发现。